B Mirror Report: Square Pharmaceuticals PLC, long regarded as a symbol of trust in the stock market, has once again come into the spotlight following a move by the company’s top executive. The Managing Director of this blue-chip pharmaceutical company has decided to purchase a large number of shares from the market personally, sending a positive signal to investors.
According to sources at the Dhaka Stock Exchange (DSE), Mr. Tapan Chowdhury, Managing Director of Square Pharmaceuticals, has expressed his intention to purchase a total of 2 million shares of the company. The DSE officially disclosed this information on Monday (January 5).
As per the DSE notice, the announced share purchase will be completed within the next 30 working days. It was stated that he may acquire these shares through either the public market or the block market.
Market analysts believe that when the Managing Director of a strong, fundamentally sound company announces a significant personal share purchase from the market, it is generally viewed as a reflection of his strong confidence in the company’s future prospects and the current market price. In the case of a company like Square Pharma, such an announcement can boost the morale of general investors.
In accordance with regulations, the share transactions will be carried out in compliance with the insider trading rules of the Bangladesh Securities and Exchange Commission (BSEC) and the listing regulations of the DSE. Once the share purchase is completed within the stipulated timeframe, the information will be disclosed again through the DSE.
Upon completion of this investment, the number of shares held by the sponsors and directors of Square Pharmaceuticals will further increase. It is worth noting that the company has long maintained investor confidence by regularly paying dividends. Given the current market conditions, market participants believe that this initiative by the Managing Director will help increase interest in pharmaceutical sector stocks and contribute to restoring momentum in the overall market.
